Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Svystonyuk, Daniyil A ^a   Ngu, Janet M C ^a   Mewhort, Holly E M ^a   Lipon, Brodie D ^a   Teng, Guoqi ^a   Guzzardi, David G ^a   Malik, Getanshu ^a   Belke, Darrell D ^a   Fedak, Paul W M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cardiac myofibroblasts; Extracellular matrix; Fibrosis

Indexed keywords

COLLAGEN; FIBROBLAST GROWTH FACTOR 2; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MYOFIBROBLAST; BIOPSY; CARDIAC MUSCLE; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; FEMALE; FIBROSIS; HEART; HEART FAILURE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

APOPTOSIS; BIOPSY; CELL DIFFERENTIATION; COLLAGEN; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; HEART; HEART FAILURE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MYOCARDIUM; MYOFIBROBLASTS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84929407211     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0510-4     Document Type: Article

References (36)

1. Fedak PW, Verma S, Weisel RD, Li RK. Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc Pathol. 2005;14(1):1-11.
2. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. CircRes. 2002;90(5):520-30.
3. Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-β signaling in fibrosis. Growth factors. 2011;29:196-202.
4. Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 2011;51(4):600-6.
5. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 2010;106:1675-80.
6. Fraccarollo D, Galuppo P, Bauersachs J. Novel therapeutic approaches to post-infarction remodelling. Cardiovasc Res. 2012;94(2):293-303.
7. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev. 2007;87(4):1285-342.
8. McGarvey JR, Pettaway S, Shuman JA, Novack CP, Zellars KN, Freels PD, et al. Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: relation to left ventricular remodeling. J Pharmacol Exp Ther. 2014;350(3):701-9.
9. Fedak PW. Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart. Semin Thorac Cardiovasc Surg. 2008;20(2):87-93.
10. Fedak PW, Bai L, Turnbull J, Ngu J, Narine K, Duff HJ. Cell therapy limits myofibroblast differentiation and structural cardiac remodeling: basic fibroblast growth factor-mediated paracrine mechanism. Circulation Heart failure. 2012;5(3):349-56.
11. Mewhort HE, Turnbull JD, Meijndert HC, Ngu JM, Fedak PW. Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling. J Thorac Cardiovasc Surg. 2014;147(5):1650-9.
12. Frangogiannis NG. Matricellular proteins in cardiac adaptation and disease. Physiol Rev. 2012;92:635-88.
13. Detillieux KA, Sheikh F, Kardami E, Cattini PA. Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res. 2003;57(1):8-19.
14. Aviles RJ, Annex BH, Lederman RJ. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2). Br J Pharmacol. 2003;140(4):637-46.
15. House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, Newman G, et al. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation. 2003;108(25):3140-8.
16. Virag JA, Rolle ML, Reece J, Hardouin S, Feigl EO, Murry CE. Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am J Pathol. 2007;171(5):1431-40.
17. Ngu JM, Teng G, Meijndert HC, Mewhort HE, Turnbull JD, Stetler-Stevenson WG, et al. Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2. Cardiovasc Pathol. 2014;23(6):335-43.
18. Mohammadi H, Janmey PA, McCulloch CA. Lateral boundary mechanosensing by adherent cells in a collagen gel system. Biomaterials. 2014;35(4):1138-49.
19. Lin S, Baye LM, Westfall TA, Slusarski DC. Wnt5b-Ryk pathway provides directional signals to regulate gastrulation movement. Journal of Cell Biology. 2010;190(2):263-79.
20. Pang Y, Ucuzian AA, Matsumura A, Brey EM, Gassman AA, Husak VA, et al. The temporal and spatial dynamics of microscale collagen scaffold remodeling by smooth muscle cells. Biomaterials. 2009;30(11):2023-31.
21. Lijnen P, Petrov V, Fagard R. Transforming growth factor-beta 1-mediated collagen gel contraction by cardiac fibroblasts. J Renin Angiotensin Aldosterone Syst. 2003;4:113-8.
22. Lijnen P, Petrov V, Rumilla K, Fagard R. Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblasts. Methods Find Exp Clin Pharmacol. 2003;25(2):79-86.
23. Driessen NJ, Cox MA, Bouten CV, Baaijens FP. Remodelling of the angular collagen fiber distribution in cardiovascular tissues. Biomech Model Mechanobiol. 2008;7(2):93-103.
24. Vaughan MB, Howard EW, Tomasek JJ. Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res. 2000;257(1):180-9.
25. Li M, Yi X, Ma L, Zhou Y. Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway. Exp Ther Med. 2013;6(5):1121-6.
26. Tiede S, Ernst N, Bayat A, Paus R, Tronnier V, Zechel C. Basic fibroblast growth factor: a potential new therapeutic tool for the treatment of hypertrophic and keloid scars. Ann Anat. 2009;191(1):33-44.
27. Narine K, De Wever O, Van Valckenborgh D, Francois K, Bracke M, DeSmet S, et al. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering. Tissue Eng. 2006;12(10):2707-16.
28. Schuliga M, Javeed A, Harris T, Xia Y, Qin C, Wang Z, et al. Transforming growth factor-β-induced differentiation of airway smooth muscle cells is inhibited by fibroblast growth factor-2. Am J Respir Cell Mol Biol. 2013;48(3):346-53.
29. Silverio-Ruiz KG, Martinez AE, Garlet GP, Barbosa CF, Silva JS, Cicarelli RM, et al. Opposite effects of bFGF and TGF-beta on collagen metabolism by human periodontal ligament fibroblasts. Cytokine. 2007;39(2):130-7.
30. Suzuki T, Akasaka Y, Namiki A, Ito K, Ishikawa Y, Yamazaki J, et al. Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats. J Hypertens. 2008;26(12):2436-44.
31. Cushing MC, Mariner PD, Liao JT, Sims EA, Anseth KS. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J. 2008;22(6):1769-77.
32. Weber K, Sun Y, Tyagi S, Cleutjens J. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol. 1994;26:279-92.
33. Grinnell F. Fibroblast-collagen-matrix contraction: growth-factor signalling and mechanical loading. Trends Cell Biol. 2000;10(9):362-5.
34. Fedak PW, Szmitko PE, Weisel RD, Altamentova SM, Nili N, Ohno N, et al. Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism. J Thorac Cardiovasc Surg. 2005;130:1430-9.
35. Ruel M, Laham RJ, Parker JA, Post MJ, Ware JA, Simons M, et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg. 2002;124(1):28-34.
36. Burstein B, Libby E, Calderone A, Nattel S. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation. 2008;117:1630-41.